Myristic acid
|
Basic information |
| Metabolite name | Myristic acid |
 | HMDB0000806 |
 |
C06424 |
 |
11005 |
| Synonyms | Myristic acid (C14:0); |
| No. of studies | 22 |
|
Basic information |
| Metabolite name | Myristic acid |
| HMDB0000806 |
|
C06424 |
|
11005 |
| Synonyms | Myristic acid (C14:0); |
| No. of studies | 22 |
|
Relationship between Myristic acid and depression (count: 22) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M001 | Type4 | remitted group vs. non-remitted group | Plasma | Human | Up |
| Study M042 | Type3 | fluoxetine group vs. control group | Plasma | Rhesus monkey | Down |
| Study M045 | Type1 | CUMS group vs. control group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Up |
| Study M048 | Type1 | CVS group vs. control group | Hippocampus | Wistar rat | Up |
| Study M084 | Type1 | melancholic depressed group vs. control group | Plasma | Human | Up |
| Study M102 | Type1 | severe MDD group vs. control group | Urine | Human | Up |
| Study M1024 | Type1 | CUMS group vs. control group | DG region of hippocampus | ICR mouse | Down |
| Study M1024 | Type1 | CUMS group vs. control group | CA1 region of hippocampus | ICR mouse | Down |
| Study M1024 | Type1 | CUMS group vs. control group | CA3 region of hippocampus | ICR mouse | Down |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | CA1 region of hippocampus | ICR mouse | Up |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | CA3 region of hippocampus | ICR mouse | Up |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | DG region of hippocampus | ICR mouse | Up |
| Study M1075 | Type1 | CSDS group vs. control group | Serum | C57BL/6J mouse | Down |
| Study M1090 | Type3 | hyperbaric oxygen treatment group vs. control group | Plasma | BALb/c mouse | Up |
| Study M207 | Type1 | depressed group vs. control group | Hippocampus | Kunming mouse | Up |
| Study M555 | Type1 | FMT group vs. control group | Liver | Sprague-Dawley rat | Up |
| Study M600 | Type2 | high-fat diet + fish oil group vs. high-fat diet group | Forebrain | C57BL/6J mouse | Up |
| Study M610 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Ventral hippocampus | C57BL/6 J mouse | Down |
| Study M668 | Type1 | PSD group vs. stroke group | Urine | Human | Down |
| Study M676 | Type1 | CVS group vs. control group | Hippocampus | Wistar rat | Up |
| Study M712 | Type1 | depression group vs. control group | Hippocampus | Cynomolgus monkey | Down |
| Study M771 | Type1 | CSDS group vs. control group | Faece | C57BL/6J mouse | Up |
| Study M838 | Type1 | MS + stranger group vs. control group | Faece | Wistar rat | Down |
| Study M838 | Type1 | MS group vs. control group | Faece | Wistar rat | Down |
| Study M838 | Type2 | MS + Lactobacillus paracasei group vs. MS group | Faece | Wistar rat | Up |
| Study M838 | Type2 | MS + stranger + Lactobacillus paracasei group vs. MS + stranger group | Faece | Wistar rat | Up |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Up |
| Study M907 | Type1 | MDD group vs. control group | Plasma | Human | Up |
| Study M981 | Type1 | Abeta oligomer group vs. control group | Serum | ICR mouse | Down |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Down |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running group vs. Abeta oligomer group | Serum | ICR mouse | Up |